Multimodality Imaging 2019
DOI: 10.1007/978-981-10-6307-7_1
|View full text |Cite
|
Sign up to set email alerts
|

Introduction to Multimodality Intravascular Imaging

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2

Citation Types

0
2
0

Year Published

2021
2021
2022
2022

Publication Types

Select...
1
1

Relationship

0
2

Authors

Journals

citations
Cited by 2 publications
(2 citation statements)
references
References 83 publications
0
2
0
Order By: Relevance
“…In this case, fluorescence imaging provided the surface projection of the targeted Cetuximab-IRDye800 agent, PA imaging showed the depth resolved optical absorption contrast from the IRDye800 and surrounding vasculature, and ultrasound imaging revealed the underlying tissue anatomy. For imaging atherosclerosis, a cardiovascular disease characterized by the accumulation of lipid plaques and several fibrous and cellular constituents, intravascular ultrasound (IVUS) and optical coherence tomography (OCT) technologies are commonly used in the clinics [16][17][18]. Recently, intravascular PA (IVPA) is also being actively studied for mapping deep tissue atherosclerosis based on high optical absorption contrast of plaque lipids in the NIR-IIb (1.5 μm-1.7 μm) optical window [19][20][21][22][23].…”
Section: Introductionmentioning
confidence: 99%
“…In this case, fluorescence imaging provided the surface projection of the targeted Cetuximab-IRDye800 agent, PA imaging showed the depth resolved optical absorption contrast from the IRDye800 and surrounding vasculature, and ultrasound imaging revealed the underlying tissue anatomy. For imaging atherosclerosis, a cardiovascular disease characterized by the accumulation of lipid plaques and several fibrous and cellular constituents, intravascular ultrasound (IVUS) and optical coherence tomography (OCT) technologies are commonly used in the clinics [16][17][18]. Recently, intravascular PA (IVPA) is also being actively studied for mapping deep tissue atherosclerosis based on high optical absorption contrast of plaque lipids in the NIR-IIb (1.5 μm-1.7 μm) optical window [19][20][21][22][23].…”
Section: Introductionmentioning
confidence: 99%
“…In this case, fluorescence imaging provided the surface projection of the targeted Cetuximab-IRDye800 agent, PA imaging showed the depth resolved optical absorption contrast from the IRDye800 and surrounding vasculature, and ultrasound imaging revealed the underlying tissue anatomy. For imaging atherosclerosis, a cardiovascular disease characterized by the accumulation of lipid plaques and several fibrous and cellular constituents, intravascular ultrasound (IVUS) and optical coherence tomography (OCT) technologies are commonly used in the clinics [13][14][15]. Recently, intravascular PA (IVPA) is also being actively studied for mapping deep tissue atherosclerosis based on high optical absorption contrast of plaque lipids in the NIR-IIb (1.5 µm -1.7 µm) optical window [16][17][18][19][20].…”
Section: Introductionmentioning
confidence: 99%